Stay up-to-date on the latest industry, member, and policy related news.
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
James (Jim) Herbert, who passed away recently, was a founding father of Michigan’s biotechnology ecosystem. He brought to his work, and to his life, a passion, a vision and a perseverance rooted in his belief that biotechnology was the way of the future. In so doing, Herbert co-founded and built Neogen, a pioneering multi-national food…
TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI)…
Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable contract manufacturer of biologics, small molecules, and vaccines, announces the completion of its finishing and warehouse center expansion. The expansion added 90,000 sq. ft. to the existing 110,000 sq. ft., totaling 200,000 sq. ft. of sophisticated inspection, packaging, testing, and warehouse capabilities. Grand River Aseptic Manufacturing…
ANN ARBOR, MI, FEBRUARY 22, 2024 – Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company’s portfolio of LNP research tools and reflects the company’s legacy of providing high-quality lipids…
As 2023 ends, we’ve been reflecting on the impact our team made on Michigan’s life sciences industry. While there were certainly challenges along the way, we’re proud of the work done here at MichBio and hope you’ve noticed our efforts to convene, connect, inform, and advocate for the statewide life sciences cluster. Some reflections on…
Legislation (HB 4167) to establish a Rare Disease Advisory Council (RDAC) in Michigan were progressing nicely through the summer following overwhelming bipartisan passage by the full House. A RDAC would empower rare disease patients as partners in helping to shape policy development relevant to the unmet needs, common struggles, and concerns on equitable, quality, and…
SB 148 and SB 149, sponsored by Sen. Polehanki and Sen. Hertel, respectively, sought to regulate the use/disposition of animals in research including mandatory reporting on numbers of animals owned, used, and released by research facilities, mandatory requirement for adoption of research animals post-use, and other restrictions and penalties. The legislation arose after an outcry…
SB 483, SB 484 and SB 485 were introduced in mid-September 2023 that would establish a new state board – a so-called Prescription Drug Affordability Board (PDAB) – that would determine how much pharmaceutical companies can charge for certain drugs by setting an “upper price limit”. According to PDAB supporters, such a body would lower…
Early fall 2023 saw a package of bills introduced that would reestablish a state research & development R&D) tax credit in Michigan – HBs 5099, 5100, 5101 and 5102. Ever since Michigan moved from the Michigan Business Tax regime to the current Corporate Income Tax regime twelve years ago, Michigan taxpayers have not been afforded…
The America Innovation and R&D Competitiveness Act of 2023 or HB 2673 was reintroduced that would repeal current rules and allow a business to deduct of R&D costs in the tax year that they occur and thereby incentivize long-term investments in innovation. Such repeal has been a top policy priority for MichBio and the bio-industry generally…
On December 7, the Biden Administration announced new efforts intended to lower prescription drug costs. While the announcement includes broader initiatives, one component would allow invoking March-In rights under the Bayh-Dole Act to license the patent rights of drugs to other biopharmaceutical manufacturers when the price of the drug is deemed to be too high. MichBio has grave…
The Federal Trade Commission (FTC) and Department of Justice (DOJ) released new merger guidelines that have implications for the life sciences industry. The new guidelines may give regulators more ammunition to go after vertical and cross-market M&A that has historically been more difficult to challenge. Private equity “roll-ups” of multiple companies may also face heightened scrutiny. The…
Original Source Tyus brings over a decade of experience in advancing health equity, improving access to the Board EAST LANSING, Mich. – The Michigan Health Information Network Shared Services (MiHIN), Michigan’s state designated health information exchange, today announced that Janée Tyus, MPH has been elected to its Board of Directors. Tyus will bring over a decade of…
ORIGINAL SOURCE TrialAssure’s proprietary AI-technology can aid in making clinical trial results available more quickly to all trial participants and the public The equivalent of one million work hours completed in less than one day using AI in honor of Health Literacy Month Plain language summaries to be released over a five-week period by disease…
ORIGINAL SOURCE Renewable electrical energy produced from anaerobic digesters could drive EV charging stations on dairy farms EAST LANSING, Mich. — One of the next climate change solutions might be found at your local dairy farm. A team of MSU researchers are studying ways to generate renewable energy from dairy farm waste to charge electric…